← All trials
NCT00293657
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2005
- Primary completion
- Apr 1, 2006
- Completion date
- Apr 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- POZENLead sponsor
- POZENOverall official - principal investigator
- Thomas Jefferson UniversityOverall official - principal investigator
- Diamond Headache ClinicOverall official - principal investigator
- California Medical Clinic for HeadacheOverall official - principal investigator
- Jean Brown ResearchOverall official - principal investigator
- Premiere Research InstituteOverall official - principal investigator
- Swedish Pain CenterOverall official - principal investigator
- Meridien ResearchOverall official - principal investigator
- Alabama Clinical TherapeuticsOverall official - principal investigator
- North Carolina Clinical ResearchOverall official - principal investigator
- The Houston Headache ClinicOverall official - principal investigator
- Little Rock Family Practice ClinicOverall official - principal investigator
- Michigan Head Pain and Neurological InstituteOverall official - principal investigator
- Clinical Research Associates, Inc.Overall official - principal investigator
- New England Center for HeadacheOverall official - principal investigator
- Mercy Health Research / Ryan Headache CenterOverall official - principal investigator
- The Innovative Clinical Research CenterOverall official - principal investigator
- Northeast Medical Research Associates, Inc.Overall official - principal investigator
- University of South AlabamaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.